Botanical species · safety record

Aquilegia vulgaris

The EFSA Compendium of Botanicals holds 6 constituent measurements for Aquilegia vulgaris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aquilegia vulgaris L.

6Constituent measurements

0Safety records

3Cited sources

12Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 12 licensed products naming Aquilegia vulgaris as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Aerial parts
Whole flowering plant

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Berberine	Roots and other underground parts	Solvent extraction	—	—	No resolvable identifier
Gallic acid	Roots and other underground parts	Solvent extraction	—	—	No resolvable identifier
Magnoflorine	Roots and other underground parts	Solvent extraction	—	—	No resolvable identifier
Octanal	Pollen-related	Essential oil	42 Percent	GC-MS	No resolvable identifier
Pentacyclic triterpene glycosides	Aerial part of plants	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Pentacyclic triterpene glycosides	Aerial part of plants	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Szaufer-Hajdrych, M., Drost-Karbowska, K., Kowalewski, Z. Phenolic acids and alkaloids in the roots of Aquilegia vulgaris L. (Ranunculaceae). part IV. Herba polonica, 1998, vol. 44, no. 3, p. 165-171.
Nishida, M., Yoshimitsu, H., Okawa, M., Noharah, T. Four new cycloartane glycosides from Aquilegia vulgaris and their immunosuppressive activities in mouse allogeneic mixed lymphocyte reaction . Chemical & pharmaceutical bulletin, 2003, vol. 51, no. 6, p. 683-687.
Juergens, Andreas., Doetterl, Stefan. Chemical composition of anther volatiles in Ranunculaceae: genera-specific profiles in Anemone, Aquilegia, Caltha, Pulsatilla, Ranunculus, and Trollius species. American journal of botany, 2004, vol. 91, no. 12, p. 1969-1980.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature